A5006566603- Long-Term Effects of COVID-19
- COVID-19 Clinical Research Studies
- Cardiovascular Function and Risk Factors
- Cardiomyopathy and Myosin Studies
- COVID-19 and healthcare impacts
- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Pericarditis and Cardiac Tamponade
- Sepsis Diagnosis and Treatment
- Heart Failure Treatment and Management
Rush University Medical Center
2021-2023
Rush University
2020
To compare the characteristics and outcomes of COVID-19 patients with a hyperdynamic LVEF (HDLVEF) to those normal or reduced LVEF.Retrospective study.Rush University Medical Center.Of 1682 adult hospitalized COVID-19, 419 had transthoracic echocardiogram (TTE) during admission met study inclusion criteria.Participants were divided into (LVEF < 50%), (≥50% <70%), (≥70%) groups.LVEF was assessed as predictor 60-day mortality. Logistic regression used adjust for age BMI.There no difference in...
In the coronavirus disease 2019 (COVID-19) global pandemic, patients with cardiovascular represent a vulnerable population higher risk for contracting COVID-19 and worse prognosis case fatality rates. However, relationship between heart failure (HF) is unclear, specifically whether HF an independent factor severe infection or if other accompanying comorbidities are responsible increased risk.This retrospective analysis of 1331 adult diagnosed March June 2020 admitted at Rush University...
Introduction: Early studies of coronavirus disease 2019 (COVID-19) patients suggested that heart failure (HF) may lead to poorer prognosis. We evaluated demographics and short-term clinical outcomes with evidence left ventricular systolic dysfunction (LVSD) in comparison those preserved LV function (PSF). Methods: In this retrospective study hospitalized for COVID-19 between March June 2, 2020 at Rush Health Systems Metro Chicago, demographics, comorbidities who demonstrated LVSD (ejection...
Background: Subcutaneous implantable cardioverter-defibrillators (S-ICDs) are an alternative to transvenous ICDs for patients without a need cardiac pacing. Obese have been proposed be at higher risk conversion failure with S-ICDs due subcutaneous fat underneath the device. Optimal device positioning may promote equivalent outcomes between obese and non-obese by minimizing effects of excess adipose tissue.Objectives: To assess whether optimal S-ICD implantation technique, as measured...